InvestorsHub Logo
Followers 0
Posts 98
Boards Moderated 0
Alias Born 06/19/2017

Re: None

Friday, 05/26/2023 8:57:17 AM

Friday, May 26, 2023 8:57:17 AM

Post# of 3990
"In clinical trials" the elfabrio site states 29% experience infusion related reactions. The fabrazyme site says 59% of its patients do.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News